Placement of endovascular embolization microcoils to localize the site of breast lesions removed at stereotactic core biopsy.

Fajardo, Laurie L.; Bird, Richard E.; Herman, Carolyn R; DeAngelis, Gia A.

doi:10.1148/radiology.206.1.9423683

Cited by 22 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the end of the 1990s, endovascular embolization microcoils were tested as biopsy site markers and demonstrated to be accurate when used in the breast [7]. Inspired by this, Dr. Belinda Curpen and colleagues [27] in Montreal came up with an alternate, low-cost clip system that consisted in a small titanium clip delivered to the biopsy site using an 18-gauge spinal needle.…”

Section: Montreal Techniquementioning

confidence: 99%

“…Before biopsy clips were introduced, lesion localization relied on identification of the biopsy site hematoma with ultrasound [6], or alternatively identification of mammographic anatomic landmarks near the lesion for preoperative wire localization [1]. However, these techniques often resulted in excision of a larger volume of breast because of their lack of precision [7]. In the absence of biopsy clips, clear margins were reported in only 31-62% of women after mammographically guided wire localization [8][9][10], but this number increased to 90% in the presence of biopsy clips [11].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

Thomassin‐Naggara

Lalonde

David

et al. 2011

Breast Cancer Res Treat

View full text Add to dashboard Cite

In the last decade, percutaneous breast biopsies have become a standard for the management of breast diseases. Biopsy clips allow for precise lesion localization, thus minimizing the volume of breast to be resected at the time of surgery. With the development of many imaging techniques (including mammography, sonography, and breast magnetic resonance imaging), one of the challenges of the multidisciplinary became to synthesize all informations obtained from the various imaging procedures. The use of biopsy markers after percutaneous biopsy is one of the keys for optimal patient management, helping the radiologist to deal with multiple lesions, to insure correlation across different imaging modalities and to follow-up benign lesions, helping the oncologist by marking a tumor prior to neoadjuvant chemotherapy, helping the surgeon by facilitating preoperative needle localization, to precisely mark the margins of extensive disease and to guide intraoperative tumor resection, and helping the pathologist to insure the lesion of interest has been removed and to identify the region of interest in a mastectomy specimen. We believe biopsy clip markers should be deployed after all percutaneous interventions and present in this review the arguments to support this statement. Minimal indications for clip deployment will also be detailed.

show abstract

Section: Montreal Techniquementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

Thomassin‐Naggara

Lalonde

David

et al. 2011

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

“…With the 14-gauge automatedlarge-coredevice, the lesion was removed in 4% of biopsiesby Hann et al [19] and in 8% of biopsies by Fajardo et al [20]. With the 14-gauge vacuum-assisted de vice, the lesion was removed in 13% of biop sies by Liberman et al [16] and in 48% of biopsies by Burbank et al [15].…”

Section: Biopsytechniques For Removal Of Benignbreastlesionsmentioning

confidence: 99%

Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques.

Jackman¹,

Marzoni²,

Nowels³

1998

American Journal of Roentgenology

View full text Add to dashboard Cite

RogerJ.FrancisA. Marzoni,Jr.2 KentW. Nowels3OBJECTIVE. The purposeof our studywas to evaluatehow often histologicallybenign lesions were completely removed as shown by the initial mammogram after biopsy. We corn pared three percutaneousbiopsy techniques.MATERIALS AND METHODS. Retrospective review wasperformedon 1206 consec utive impalpable breast lesions having percutaneous stereotactic biopsies done on a prone bi opsy table using 14-gauge automated large-core needles (n = 721); 14-gauge directional vacuum-assisted probes (n = 192); and 1I-gauge directional vacuum-assisted probes (n = 293). Lesions that were histologically benign and that did not have subsequent surgical cxci sion had mammographic follow-up. The 667 initial mammograms after biopsy (advised to be doneat 6 or 12 monthsand accomplishedat 1â€"53 months[median,7 months]after biopsy) were reviewed to see if the lesions were no longer apparent.RESULTS. The lesion was absentin 9% (40/422) of lesionsfor which 14-gaugelarge core biopsy was used, 22% (21/95) of lesions for which 14-gauge vacuum-assistedbiopsy was used, and 64% (96/150) of lesions for which I I-gauge vacuum-assisted biopsy was used

show abstract

“…The aim of these devices is to act as markers in case of tumor disappearance, in order to perform a correct surgical excision. Radiologists have also used markers after core biopsies or directional-vacuum assisted biopsies to localize the exact site of the tumor, because the lesion may disappear with those procedures [6,7,8,9,10]. The technique reported herein is a new application for coils in breast interventional procedures helping to select the best approach for the biopsy of difficult-to-localize breast lesions.…”

Section: Discussionmentioning

confidence: 99%

Clip placement facilitating the approach to breast lesions

et al. 2001

View full text Add to dashboard Cite

We describe a novel technique for marking non-palpable breast lesions with the aim of selecting the best approach prior to performing a biopsy. The technique employs a new coil, specifically designed for breast localization, guided by stereotaxy. This technique is reserved for selected cases in which the lesion is seen peripherally in only one mammographic view with negative or non-conclusive ultrasonographic results, and deeply seated after a stereotactic study. Once the coil is released beside the lesion, the shortest approach from the skin may be employed to perform the biopsy. To our knowledge, this is the first report of this technique.

show abstract

Placement of endovascular embolization microcoils to localize the site of breast lesions removed at stereotactic core biopsy.

Cited by 22 publications

References 0 publications

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques.

Clip placement facilitating the approach to breast lesions

Contact Info

Product

Resources

About